Hyderabad based Matrix Labs has partnered with the Bill Clinton Foundation to supply second-line antiretroviral (ARV) drug to treat HIV. The drug is available as three separate pills costing the patient about Rs 20,000 ($475) annually. Matrix Labs will supply the drug at a discounted price of $425, starting next year as it proposes to sell three pills in a package. The new product is available to governments that are members of the Clinton Foundationâ€™s Procurement Consortium across Africa, Asia, Latin America and the Caribbean. The products will include the first-ever heat-stable version of Ritonavir (one of the three pills), which does not require continuous refrigeration for its transport and distribution.
Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More